Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Cruz

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Cellular cartography reveals mouse prostate organization and determinants of castration resistanceHanbyul Cho, Yuping Zhang, Jean C Tien, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Cellular cartography reveals mouse prostate organization and determinants of castration resistanceHanbyul Cho, Yuping Zhang, Jean C Tien, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapyYi Bao, Yuanyuan Qiao, Jae Eun Choi, et al.
Annals of Vascular Surgery|January 24, 2025
Higher Rate of Reinterventions after Transfemoral Carotid Artery Stenting in Symptomatic Patients: A Retrospective Stroke Center's Cohort Study Between 2015-2024Camila Esquetini-Vernon, James F Meschia, Josephine Huang, et al.
Cancer Discovery|November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint BlockadeYi Bao, Gabriel Cruz, Yuping Zhang, et al.
Cell Reports. Medicine|October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibitionYu Chang, Xiaoju Wang, Jianzhang Yang, et al.
The Journal of Clinical Investigation|September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical modelsYi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinomaJean Ching-Yi Tien, Yali Zhai, Rong Wu, et al.
The European Respiratory Journal|July 16, 2021
Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX studyOrlando R Perez-Nieto, Diego Escarraman-Martinez, Manuel A Guerrero-Gutierrez, et al.
Proceedings. Biological Sciences|November 25, 2025
Collaborative research networks as a strategy to synthesize knowledge of Amazonian biodiversityBethânia Oliveira Resende, Leandro Juen, Juliana Schietti, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Cellular cartography reveals mouse prostate organization and determinants of castration resistanceHanbyul Cho, Yuping Zhang, Jean C Tien, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Cellular cartography reveals mouse prostate organization and determinants of castration resistanceHanbyul Cho, Yuping Zhang, Jean C Tien, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapyYi Bao, Yuanyuan Qiao, Jae Eun Choi, et al.
Annals of Vascular Surgery|January 24, 2025
Higher Rate of Reinterventions after Transfemoral Carotid Artery Stenting in Symptomatic Patients: A Retrospective Stroke Center's Cohort Study Between 2015-2024Camila Esquetini-Vernon, James F Meschia, Josephine Huang, et al.
Cancer Discovery|November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint BlockadeYi Bao, Gabriel Cruz, Yuping Zhang, et al.
Cell Reports. Medicine|October 1, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibitionYu Chang, Xiaoju Wang, Jianzhang Yang, et al.
The Journal of Clinical Investigation|September 16, 2025
CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical modelsYi Bao, Yu Chang, Jean Ching-Yi Tien, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinomaJean Ching-Yi Tien, Yali Zhai, Rong Wu, et al.
The European Respiratory Journal|July 16, 2021
Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX studyOrlando R Perez-Nieto, Diego Escarraman-Martinez, Manuel A Guerrero-Gutierrez, et al.
Proceedings. Biological Sciences|November 25, 2025
Collaborative research networks as a strategy to synthesize knowledge of Amazonian biodiversityBethânia Oliveira Resende, Leandro Juen, Juliana Schietti, et al.
Pageof 3